| Dermal Cell News 3.12 April 10, 2017 | |
|
|
|
|
TOP STORYEpigenetic Regulation of KPC1 Ubiquitin Ligase Effects the NF-κB Pathway in Melanoma The authors investigated the mechanisms regulating KPC1 expression and its clinical impact in melanoma. They verified that KPC1 suppresses melanoma proliferation by processing NF-κB1 p105 into p50, thereby modulating NF-κB-target gene expression. [Clin Cancer Res] Abstract |
|
|
|
|
PUBLICATIONS(Ranked by impact factor of the journal)DERMAL STEM CELLS & TISSUE REGENERATIONCutaneous Applied Nano-ZnO Reduce the Ability of Hair Follicle Stem Cells to Differentiate Researchers tested the effects of nano-zinc oxide (nZnO) on hair follicle physiology. Topical application of Vaseline containing nZnO, bulk ZnO, or ionized Zn to newborn mice vibrissa pads over a period of seven consecutive days revealed that nZnO accumulated within hair follicles, and this induced the apoptosis of hair follicle stem cells. [Nanotoxicology] Abstract The authors investigated the anti-melanogenic effects of 3,8-dihydroxyquinoline (jineol) isolated from S. subspinipes mutilans, the mechanisms responsible for its inhibition of melanogenesis in melan-a cells, and its antioxidant efficacy. Jineol significantly inhibited mushroom tyrosinase activity by functioning as an uncompetitive inhibitor, and markedly inhibited melanin production and intracellular tyrosinase activity in melan-a cells. [Sci Rep] Full Article Polyphenol-rich C. arabica extract (CAE) was investigated for its antioxidant and anti-inflammatory properties, as well as for its capability to alleviate ultraviolet B-induced photodamage in BALB/c hairless mice. The results indicated that CAE exhibited a reducing power of 94.7%, ferrous ion chelating activity of 46.4%, and hydroxyl radical scavenging activity of 20.3%. The CAE dose dependently reduced UVB-induced reactive oxygen species generation in fibroblasts. [Int J Mol Sci] Full Article SKIN CANCERS & DISORDERSScientists found that histidine triad nucleotide-binding protein 1 (HINT1) was subjected to K21 acetylation and Y109 phosphorylation in activated mast cells, together with the Ap4A-triggered HINT1 dissociation from microphthalmia transcription factor (MITF). Mutational analysis confirmed that these modifications promote MITF transcriptional and oncogenic activity in melanoma cell lines, derived from human melanoma patients. [Oncogene] Abstract Abl Kinase Regulation by BRAF/ERK and Cooperation with Akt in Melanoma Researchers demonstrated that BRAFV600E/ERK play a critical role in binding, phosphorylating and regulating Abl localization and Abl/Arg activation by Src family kinases. Abl/Arg activation downstream of BRAFV600E has functional and biological significance, driving proliferation, invasion, as well as switch in epithelial-mesenchymal-transition transcription factor expression, which is known to be critical for melanoma cells to shift between differentiated and invasive states. [Oncogene] Abstract Experimental Atopic Dermatitis Depends on IL-33R Signaling via MyD88 in Dendritic Cells Investigators report that MyD88 signaling is crucial in the pathogenesis of experimental atopic dermatitis induced by vitamin D3 analog MC903. The clinical signs and inflammation caused by MC903 were drastically reduced in MyD88−/− mice with diminished eosinophil, neutrophil infiltration and Th2 cytokine expression. [Cell Death Dis] Full Article Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma Scientists showed that BMK1 pathway contributes to the drug resistance to combined inhibition of BRAF and MEK1/2. Phosphorylation of 239 proteins were identified to be downregulated, while phosphorylation of 47 proteins were upregulated. It was found that phosphorylation of BMK1 was enhanced in resistant cells, which suggested an association of BMK1 with drug resistance. [Sci Rep] Full Article Investigators describe the evaluation of an electrostatic complex of cationic phosphorus dendrimer and rose bengal in such aspects as singlet oxygen production, cellular uptake, and phototoxicity against three basal cell carcinoma cell lines. Obtained results showed that the singlet oxygen production in aqueous medium was significantly higher for the complex than for free rose bengal. [Mol Pharm] Abstract | Graphical Abstract Nitric Oxide Donor Augments Antineoplastic Effects of Arginine Deprivation in Human Melanoma Cells Researchers evaluated the effects of an exogenous nitric oxide (NO) donor, sodium nitroprusside, on viability and metastatic properties of two human melanoma cell lines SK-MEL-28 and WM793 under arginine-deprived conditions. They revealed that NO did not rescue melanoma cells from specific effects evoked by arginine deprivation, namely decreased viability and induction of apoptosis, dramatically reduced motility, invasiveness and clonogenic potential. [Exp Cell Res] Abstract |
|
|
|
|
REVIEWSTargeted Agents and Immunotherapies: Optimizing Outcomes in Melanoma The authors review the clinical trial data that established the standard-of-care treatment approaches for advanced-stage melanoma. Mechanisms of resistance and biomarkers of response to BRAF-targeted treatments and immunotherapies are discussed, and the contrasting clinical benefits and limitations of these therapies are explored. [Nat Rev Clin Oncol] Abstract Visit our reviews page to see a complete list of reviews in the dermal cell research field. |
|
|
|
|
SCIENCE NEWSLong Term Benefits of Immunotherapy Emerging for Some Patients, though Key Questions Remain A number of cancer clinical trials involving immunotherapy treatments appear to be showing promise, according to new research. The findings follow initial excitement around the drugs in recent years, and make early estimates of the possible long term benefits for some patients. But questions still remain over which patients should receive the treatments, how extensive side effects are, and how to address where immunotherapy hasn’t been successful. [Press release from the Cancer Research UK discussing research presented at the 2017 American Association for Cancer Research, Washington, D.C.] Press Release | Abstract Bristol-Myers Squibb Company announced the first overall survival (OS) data from the Phase III CheckMate -067 clinical trial. With a minimum follow-up of 28 months, the median OS had not yet been reached in either of the two Opdivo treatment groups and was 20 months for the Yervoy monotherapy group. Opdivo in combination with Yervoy and as a monotherapy reduced the risk of death 45% and 37%, respectively, compared with Yervoy alone. [Press release from Bristol-Myers Squibb Company discussing research presented at the 2017 American Association for Cancer Research, Washington, D.C.] Press Release OncoSec Medical Incorporated presented a poster titled “Intratumoral Delivery of a P2A-linked Bicistronic IL-12 Construct Leads to High Intratumoral Expression and Systemic Anti-tumor Response”. The poster included preclinical data demonstrating the latest developments of OncoSec’s gene delivery platform in a murine melanoma model. [Press release from OncoSec Medical Incorporated discussing research presented at the 2017 American Association for Cancer Research, Washington, D.C.] Press Release | Abstract |
|
|
|
|
INDUSTRY NEWSResearchers Named Outstanding Investigators by the National Cancer Institute Stanford cancer researchers Ronald Levy and Howard Chang have been named Outstanding Investigators by the National Cancer Institute. They were awarded grants of up to $7 million over six years to advance their studies. [Stanford Medicine] Press Release Stand Up To Cancer announced the award of $7.5 million in Innovative Research Grants focused on immuno-oncology to ten early-career scientists, in a program funded by a grant from Bristol-Myers Squibb Company. These awards were announced at the 2017 Annual Meeting of the American Association for Cancer Research (AACR). [Stand Up To Cancer (PR Newswire Association LLC.)] Press Release | |
|
|
|
POLICY NEWSCongress and FDA Nominee Heap Love on ‘Adaptive Trials’ As President Donald Trump’s nominee to head FDA, Gottlieb sat before Republican lawmakers hungry for promises of “shorter time frames” for drug and device approvals, and expressed his zeal—repeatedly—for adaptive trial designs. If confirmed to be FDA’s head, as expected, Gottlieb suggested he’d promote wider use of the approach. [ScienceInsider] Editorial Geophysics Society Hopes to Define Sexual Harassment as Scientific Misconduct A major U.S.-based scientific society is on the verge of expanding its definition of research misconduct to include sexual harassment. The American Geophysical Union is making the change to emphasize the serious threat that harassment and other forms of discrimination pose to the scientific enterprise, say society officials. [ScienceInsider] Editorial
|
|
EVENTSNEW ISSCR Annual Meeting 2017 Visit our events page to see a complete list of events in the community.
|
|
JOB OPPORTUNITIESNEW Scientist – Cell Biology and Autoimmune Disease (Immunocore) Postdoctoral Fellow – Melanoma (Icahn School of Medicine at Mount Sinai) Postdoctoral Research Fellow – Skin Epigenetics (Boston University) Researcher and Teacher – Skin and Venereal Diseases (Humanitas University) Postdoctoral Fellow/Research Assistant – Psoriasis (University of California, Davis) Two Postdoctoral Positions – Melanoma (Moffitt Cancer and Research Institute) Clinical Research Fellow – Melanoma (CRUK Manchester Institute) Professorships – Tissue Engineering and Regenerative Medicine (The Chinese University of Hong Kong) Postdoctoral Training Fellow – Aryl Hydrocarbon Receptor (The Francis Crick Institute) Postdoctoral Fellowship – Atopic Dermatitis (Boston Children’s Hospital) Junior Research Group Leader – Analytics and Toxicology (The Federal Institute for Risk Assessment)
Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
|
|
|
Have we missed an important article or publication in Dermal Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. |
|
|

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News


